DK0475291T3 - Fra kylling afledt biologisk aktivt peptid (kylling CNP) - Google Patents

Fra kylling afledt biologisk aktivt peptid (kylling CNP)

Info

Publication number: DK0475291T3
Authority: DK; Denmark
Prior art keywords: chicken; biologically active; cnp; active peptide; derived biologically
Prior art date: 1990-09-07

Application number

DK91115080T

Other languages

English (en)

Inventor

Hisayuki Matsuo

Kenji Kangawa

Naoto Minamino

Original Assignee

Hisayuki Matsuo

Suntory Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-07

Filing date

1991-09-06

Publication date

1999-08-30

1991-09-06 Application filed by Hisayuki Matsuo, Suntory Ltd filed Critical Hisayuki Matsuo

1999-08-30 Application granted granted Critical

1999-08-30 Publication of DK0475291T3 publication Critical patent/DK0475291T3/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
241000287828 Gallus gallus Species 0.000 title abstract 2
101000796284 Gallus gallus C-type natriuretic peptide Proteins 0.000 title 1
238000000034 method Methods 0.000 abstract 2
210000004556 brain Anatomy 0.000 abstract 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000010353 genetic engineering Methods 0.000 abstract 1
230000001452 natriuretic effect Effects 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1
230000002541 vasodepressive effect Effects 0.000 abstract 1
239000003071 vasodilator agent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK91115080T 1990-09-07 1991-09-06 Fra kylling afledt biologisk aktivt peptid (kylling CNP) DK0475291T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2238293A JP2977158B2 (ja)	1990-09-07	1990-09-07	トリ由来新規生理活性ペプチド（ニワトリｃｎｐ）

Publications (1)

Publication Number	Publication Date
DK0475291T3 true DK0475291T3 (da)	1999-08-30

Family

ID=17028039

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK91115080T DK0475291T3 (da)	1990-09-07	1991-09-06	Fra kylling afledt biologisk aktivt peptid (kylling CNP)

Country Status (8)

Country	Link
US (1)	US5338830A (da)
EP (1)	EP0475291B1 (da)
JP (1)	JP2977158B2 (da)
AT (1)	ATE175210T1 (da)
DE (1)	DE69130696T2 (da)
DK (1)	DK0475291T3 (da)
ES (1)	ES2127190T3 (da)
GR (1)	GR3029628T3 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0203172B8 (pt)	2001-09-28	2021-05-25	Nakao Kazuwa	composição farmacêutica para acondroplasia
EP3620530A1 (en)	2004-03-31	2020-03-11	Kazuwa Nakao	Composition for increasing body height
WO2005094889A1 (ja)	2004-03-31	2005-10-13	Chugai Seiyaku Kabushiki Kaisha	関節炎症治療剤又は予防剤
PL2348114T3 (pl)	2004-04-21	2019-08-30	Alexion Pharmaceuticals, Inc.	Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
EP2658979B1 (en)	2010-12-27	2018-02-14	Alexion Pharmaceuticals, Inc.	Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en)	2012-05-21	2018-08-21	Alexion Pharmaceuticsl, Inc.	Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en)	2014-07-11	2020-11-03	Alexion Pharmaceuticals, Inc.	Compositions and methods for treating craniosynostosis
WO2016090251A1 (en)	2014-12-05	2016-06-09	Alexion Pharmaceuticals, Inc.	Treating seizure with recombinant alkaline phosphatase
US10603361B2 (en)	2015-01-28	2020-03-31	Alexion Pharmaceuticals, Inc.	Methods of treating a subject with an alkaline phosphatase deficiency
TW201717990A (zh) *	2015-07-31	2017-06-01	Igisu Co Ltd	Cnp環狀胜肽及含此環狀胜肽之醫藥品、外用劑及化粧品
AU2016308624B2 (en)	2015-08-17	2022-06-23	Alexion Pharmaceuticals, Inc.	Manufacturing of alkaline phosphatases
EP3355904A4 (en)	2015-09-28	2019-06-12	Alexion Pharmaceuticals, Inc.	IDENTIFICATION OF EFFECTIVE DOSE SHEETS FOR TISSUE-SPECIFIC ALKALINE PHOSPHATASE ENZYMERSAT THERAPY OF HYPOPHOSPHATASIA
JP2018533571A (ja)	2015-10-30	2018-11-15	アレクシオンファーマシューティカルズ，インコーポレイテッド	患者の頭蓋縫合早期癒合症を治療するための方法
EP3426286A4 (en)	2016-03-08	2019-12-04	Alexion Pharmaceuticals, Inc.	PROCESS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN
WO2017173395A1 (en)	2016-04-01	2017-10-05	Alexion Pharmaceuticals, Inc.	Methods for treating hypophosphatasia in adolescents and adults
KR20180125979A (ko)	2016-04-01	2018-11-26	알렉시온 파마슈티칼스, 인코포레이티드	알칼리성 포스파타아제로 근육 약화의 치료
US10988744B2 (en)	2016-06-06	2021-04-27	Alexion Pharmaceuticals, Inc.	Method of producing alkaline phosphatase
JP7018933B2 (ja)	2016-08-18	2022-02-14	アレクシオンファーマシューティカルズ，インコーポレイテッド	気管気管支軟化症の治療方法
MX2019011508A (es)	2017-03-31	2019-11-01	Alexion Pharma Inc	Metodos para tratar la hipofosfatasia (hpp) en adultos y adolescentes.
US11913039B2 (en)	2018-03-30	2024-02-27	Alexion Pharmaceuticals, Inc.	Method for producing recombinant alkaline phosphatase
JP7820148B2 (ja)	2018-08-10	2026-02-25	アレクシオンファーマシューティカルズ，インコーポレイテッド	アルカリホスファターゼを用いて神経線維腫症１型および関連状態を治療する方法
MX2022007114A (es)	2019-12-09	2022-07-11	Alexion Pharma Inc	Polipeptidos de fosfatasa alcalina y metodos de uso de los mismos.
MX2023002673A (es)	2020-09-04	2023-05-12	Alexion Pharma Inc	Métodos para el tratamiento de trastornos de mineralización ósea.
EP4291224A4 (en)	2021-02-12	2025-01-01	Alexion Pharmaceuticals, Inc.	Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2544929B2 (ja) *	1987-06-17	1996-10-16	第一化学薬品株式会社	新規生理活性ペプチド
US5114923A (en) *	1988-05-31	1992-05-19	California Biotechnology Inc.	Recombinant techniques for production of novel natriuretic and vasodilator peptides

1990
- 1990-09-07 JP JP2238293A patent/JP2977158B2/ja not_active Expired - Fee Related
1991
- 1991-09-04 US US07/754,947 patent/US5338830A/en not_active Expired - Fee Related
- 1991-09-06 ES ES91115080T patent/ES2127190T3/es not_active Expired - Lifetime
- 1991-09-06 DE DE69130696T patent/DE69130696T2/de not_active Expired - Fee Related
- 1991-09-06 AT AT91115080T patent/ATE175210T1/de not_active IP Right Cessation
- 1991-09-06 DK DK91115080T patent/DK0475291T3/da active
- 1991-09-06 EP EP91115080A patent/EP0475291B1/en not_active Expired - Lifetime
1999
- 1999-03-09 GR GR990400718T patent/GR3029628T3/el unknown

Also Published As

Publication number	Publication date
GR3029628T3 (en)	1999-06-30
EP0475291A1 (en)	1992-03-18
ES2127190T3 (es)	1999-04-16
DE69130696D1 (de)	1999-02-11
DE69130696T2 (de)	1999-06-10
JPH04120094A (ja)	1992-04-21
US5338830A (en)	1994-08-16
JP2977158B2 (ja)	1999-11-10
ATE175210T1 (de)	1999-01-15
EP0475291B1 (en)	1998-12-30

Publication	Publication Date	Title
GR3029628T3 (en)	1999-06-30	A novel biologically active peptide derived from chicken (chicken CNP)
GR3029632T3 (en)	1999-06-30	A novel biologically active peptide derived from frog (frog CNP)
BR1100989A (pt)	1999-11-09	Composto e composição de matéria
FI924453A0 (fi)	1992-10-02	Nya 9-amino-7-(substituerad)-6-demetyl-6-deoxitetracykliner
DE69020794D1 (de)	1995-08-17	Enzymatische Entfernung einer aminoterminalen Proteinsequenz.
ATE87006T1 (de)	1993-04-15	Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
DE69219590D1 (de)	1997-06-12	BPC-Peptide, deren Herstellung und Verwendung
ATE162079T1 (de)	1998-01-15	Verwendung von antikörper enthaltenden präparationen zur immunsuppression
NO895028D0 (no)	1989-12-14	Ny chimerisk transformerende vekstfaktor-beta.
HUT46933A (en)	1988-12-28	Process for producing cyclic peptides of anticoagulant activity
HUT51295A (en)	1990-04-28	Process for producing peptidalcohol derivatives of anticoagulant activity
EP0317627A4 (en)	1990-12-12	Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
DE69127303D1 (de)	1997-09-25	Substituierte Triazolopyridazine
ATE94588T1 (de)	1993-10-15	Verfahren zur herstellung und reinigung von alpha-interferon.
ES2124694T3 (es)	1999-02-16	Clonacion de la n-metil-hidantoinasa.
FR2520740B1 (da)	1984-03-09
ATE130630T1 (de)	1995-12-15	Sg(beta)-1,4-galaktanase und dns-sequenz.
ATE133709T1 (de)	1996-02-15	Peroxidase-gen von mikrobischem ursprung
ES2079054T3 (es)	1996-01-01	Peptidilhidroxiglicina n-c-liasa y adn codificante de la misma.
DE59602774D1 (de)	1999-09-23	Verfahren zur Herstellung von 3.3.5-Trimethylcyclohexanon
ATE116336T1 (de)	1995-01-15	Bakteriozin-peptid.
ES2059766T3 (es)	1994-11-16	Precursor de prostaglandinas y su produccion.
FR2551088B1 (da)	1985-12-06
ATE102997T1 (de)	1994-04-15	Thymosin und tnf-kodierende dna.
EP1295943A4 (en)	2005-11-16	POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES